Top-News

Vinings Holdings Inc. News

Aktie
WKN:  ISIN:  US92744A1051 US-Symbol:  COEP
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

Vinings Holdings Inc. News

28.08.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYBR, UNP, COEP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYBR, UNP, COEP on Behalf of Shareholders PR Newswire
03.07.25 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT PR Newswire
06.05.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders PR Newswire
28.04.25 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEP
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEP PR Newswire
06.02.25 - PR Newswire
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration PR Newswire
30.01.25 - PR Newswire
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation PR Newswire
22.01.25 - PR Newswire
Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2) PR Newswire
07.01.25 - PR Newswire
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform PR Newswire
27.12.24 - PR Newswire
Coeptis Therapeutics Announces Reverse Stock Split
Coeptis Therapeutics Announces Reverse Stock Split PR Newswire
26.12.24 - PR Newswire
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies PR Newswire

Newssuche

Videos

newspaper
09:50 Uhr +3,41%
Technical Trading: Neues Allzeithoch im Visier
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »